已选(0)清除
条数/页: 排序方式: |
| Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p 期刊论文 Science Bulletin, 2021 作者: Tong Y.; Zhang J.; Sun N.; Wang X.-M.; Wei Q.; Zhang Y.; Huang R.; Pu Y.; Dai H.; Ren B.; Pei G.; Song F.; Zhu G.; Wang X.; Xia X.; Chen X.; Jiang L.; Wang S.; Ouyang L.; Xie N.; Zhang B.; Jiang Y.; Liu X.; Calderone R.; Bai F.; Zhang L.; Alterovitz G. 收藏  |  浏览/下载:43/0  |  提交时间:2021/09/01 Berberine Candida albicans Drug excretion transporter Mitochondria Multidrug-resistance |
| In situ observation of cracking and self-healing of solid electrolyte interphases during lithium deposition 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 17 作者: Yang T.; Li H.; Tang Y.; Chen J.; Ye H.; Wang B.; Zhang Y.; Du C.; Yao J.; Guo B.; Shen T.; Zhang L.; Zhu T.; Huang J. 收藏  |  浏览/下载:43/0  |  提交时间:2021/09/01 Environmental transmission electron microscopy Lithium batteries Lithium whisker Solid electrolyte interphase |
| The Rhinolophus affinis bat ACE2 and multiple animal orthologs are functional receptors for bat coronavirus RaTG13 and SARS-CoV-2 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 12 作者: Li P.; Guo R.; Liu Y.; Zhang Y.; Hu J.; Ou X.; Mi D.; Chen T.; Mu Z.; Han Y.; Chen Z.; Cui Z.; Zhang L.; Wang X.; Wu Z.; Wang J.; Jin Q.; Qian Z. 收藏  |  浏览/下载:30/0  |  提交时间:2021/09/01 Bat coronavirus RaTG13 Coronavirus entry Host susceptibility Rhinolophus affinis bat ACE2 SARS-CoV-2 Spike protein |
| Recent leveling off of vegetation greenness and primary production reveals the increasing soil water limitations on the greening Earth 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 14 作者: Feng X.; Fu B.; Zhang Y.; Pan N.; Zeng Z.; Tian H.; Lyu Y.; Chen Y.; Ciais P.; Wang Y.; Zhang L.; Cheng L.; Maestre F.T.; Fernández-Martínez M.; Sardans J.; Peñuelas J. 收藏  |  浏览/下载:33/0  |  提交时间:2021/09/01 Ensemble empirical mode decomposition Global carbon cycle Global vegetation primary productivity Global warming Leveling off of Earth greening Soil water limitation |
| Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS) 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 15 作者: Jia W.; Ma J.; Miao H.; Wang C.; Wang X.; Li Q.; Lu W.; Yang J.; Zhang L.; Yang J.; Wang G.; Zhang X.; Zhang M.; Sun L.; Yu X.; Du J.; Shi B.; Xiao C.; Zhu D.; Liu H.; Zhong L.; Xu C.; Xu Q.; Liang G.; Zhang Y.; Li G.; Gu M.; Liu J.; Yuan G.; Yan Z.; Yan D.; Ye S.; Zhang F.; Ning Z.; Cao H.; Pan D.; Yao H.; Lu X.; Ji L. 收藏  |  浏览/下载:39/0  |  提交时间:2021/09/01 Chiglitazar Glycemic control Insulin resistance PPAR pan-agonist Type 2 diabetes |